Savara
SVRA
#5728
Rank
S$1.40 B
Marketcap
S$6.91
Share price
1.41%
Change (1 day)
99.37%
Change (1 year)

Earnings for Savara (SVRA)

Earnings in 2025 (TTM): -S$0.16 Billion

According to Savara's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -S$0.13 Billion a decrease over its 2023 earnings that were of -S$70.03 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Savara from 2002 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -S$0.16 Billion23.86%
2024 -S$0.13 Billion75.29%
2023 -S$70.03 Million43.38%
2022 -S$48.84 Million-11.31%
2021 -S$55.07 Million-13.3%
2020 -S$63.52 Million-36.53%
2019 -S$0.11 Billion13.76%
2018 -S$87.97 Million105.54%
2017 -S$42.8 Million34.11%
2016 -S$31.92 Million-37.43%
2015 -S$51.01 Million38.81%
2014 -S$36.75 Million33.62%
2013 -S$27.5 Million38.49%
2012 -S$19.86 Million24.59%
2011 -S$15.94 Million-36.5%
2010 -S$25.1 Million-3.14%
2009 -S$25.92 Million-23.28%
2008 -S$33.78 Million8.52%
2007 -S$31.13 Million-34.14%
2006 -S$47.26 Million184.43%
2005 -S$16.62 Million90.75%
2004 -S$8.72 Million190.35%
2003 -S$3 Million11.64%
2002 -S$2.69 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
OPKO Health
OPK
-S$0.21 Billion 37.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
-S$23.25 Million-84.30%๐Ÿ‡บ๐Ÿ‡ธ USA